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Description
The Chronic Pain Grade Questionnaire (CPGQ) is a seven-
item instrument designed to evaluate overall severity of 
chronic pain based on two dimensions, pain intensity and 
pain-related disability, in individuals who suffer from 
chronic pain that has lasted for at least six months. The 
notion of graded classiﬁcation of chronic pain severity 
was derived from the dysfunctional chronic pain concept 
provided by Turk and Rudy (1988). The two disability items 
were adopted from the Multidimensional Pain inventory 
(Von Korff et al 1992). The CPGQ was designed such that 
the graded classiﬁcation corresponds to the qualitative 
difference in global severity amongst patients with chronic 
pain (Von Korff et al 1990, Von Korff et al 1992). CPGQ 
has been translated into English (UK), German, Italian 
and Chinese languages and is available from the original 
reference and/or by contacting the authors directly.
The responses on the 7 items are used for computing the 
scores for the 3 subscales of the CPGQ: characteristic 
pain intensity, disability score, and disability points. The 
characteristic pain intensity score ranges from 0 to 100 
and is evaluated by calculating the mean of pain intensities 
reported for current pain status, as well as the worst and 
the average pain in last 6 months. The disability score (0–
100) is based on the mean ratings of how much the pain 
has interfered in performing activities of daily living, work 
and social activities in the last 6 months. The disability 
points are scored 0–3 and are derived from a combination 
of ranked categories of the number of disability days (the 
number of days that the respondent was away from usual 
activities in the last 6 months due to pain) and disability 
score. Based on these scores, the respondent’s chronic pain 
and disability status can then be classiﬁed into one of the 5 
hierarchical categories of chronic pain/disability: no pain 
(Grade 0), low disability and low intensity (Grade I), low 
disability and high intensity (Grade II), high disability and 
moderately limiting intensity (Grade III), high disability 
and severely limiting intensity (Grade IV) (Von Korff et 
al 1992).  Being a patient-reported measure, the CPGQ is 
extremely easy to administer, score, and interpret, therefore 
it requires minimal training. The administrative burden of 
the CPGQ is less than 10 minutes.
Reliability, validity and responsiveness: CPGQ was 
originally administered via telephone interviews for 
patients with back pain, headache, and temporomandibular 
joint pain. However, subsequent research has expanded its 
utility in postal surveys in general population and chronic 
musculoskeletal pain. It was found to have good correlation 
with the equivalent dimensions of SF-36 questionnaire; 
highest for pain and least for mental health dimension 
(convergent validity). Factor analyses demonstrated that all 
the seven items contributed signiﬁcantly to the explained 
variance (> 75%) (Smith et al 1997). Furthermore, moderate 
to good internal consistency (Cronbach’s alpha, 0.74 to 
0.91) and good test retest reliability has been demonstrated 
in primary care patients with back pain (weighted kappa 
–0.81, 95% CI 0.65 to 0.98) (Smith et al 1997). A study 
by Elliot et al showed that changes in CPGQ score over 
a period of time in patients with chronic musculoskeletal 
pain correlated signiﬁcantly with changes in SF-36 scores 
(Elliott et al 2000). Responsiveness statistics and minimal 
clinically important difference (MCID) of the CPGQ have 
not been reported in the literature.
Commentary
CPGQ is a reliable and valid measure for evaluation of 
chronic pain in the general population as well as in the 
primary health care setting. A recent study demonstrated 
that even though CPGQ was developed prior to the WHO 
International Classiﬁcation of Functioning, Disability 
& Health (ICF), it measures all the ICF outcomes 
ie, impairment, activity limitation and participation 
restriction (Dixon et al 2007). This is the most signiﬁcant 
advantage of CPGQ over many other pain questionnaires 
as it not only evaluates the severity of chronic pain but 
also examines its impact on activity and participation. 
Individuals with chronic pain often experience signiﬁcant 
functional impairment as well as difﬁculty in occupational/
social roles. The CPGQ may not provide a comprehensive 
assessment of how ongoing pain affects the functions and 
participation in life roles; however it can be utilised as a 
preliminary assessment tool to ascertain the extent of 
disablement resulting from chronic pain. Further research 
is required to determine if the 5 categories of CPGQ allow 
thorough and consistent discrimination of pain severity and 
disability among individuals with varying degree of pain/
disablement. Hence, CPGQ with further validation can 
facilitate individualised management tailored according 
to the clinical subgroup of the patient (high pain versus 
high disability). Lastly, responsiveness and MCID of the 
subscales of the CPGQ need to be established in prospective 
longitudinal studies.
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